Bromide

Bromide

SCHEMBL4334733

Br.Nc1cccc(-c2cccc([N+](=O)[O-])c2O)c1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 2/20 0.53
ALOX15 P16050 2/20 0.46
MAPK1 P28482 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
HSD17B10 Q99714 1/20 0.46
CRHBP P24387 1/20 0.45
CRHR2 Q13324 1/20 0.45
ALDH1A1 P00352 3/20 0.45
TDP1 Q9NUW8 3/20 0.45
ERN1 O75460 1/20 0.44
S100A4 P26447 2/20 0.44
F2 P00734 1/20 0.41
F10 P00742 1/20 0.41
PLG P00747 1/20 0.41
PLAU P00749 1/20 0.41
PLAT P00750 1/20 0.41
PRSS1 P07477 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
CA1 P00915 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2405410 0.98 GPR35 (0.55) GPR35ALOX15MAPK1L3MBTL1HSD17B10
SCHEMBL10711666 0.84 ALDH1A1 (0.65) ALOX15MAPK1L3MBTL1HSD17B10CRHBP
SCHEMBL5605382 0.80 TDP1 (0.69) GPR35MAPK1CRHBPCRHR2ALDH1A1
SCHEMBL6797781 0.80 TDP1 (0.46) GPR35ALOX15MAPK1L3MBTL1HSD17B10
SCHEMBL11309776 0.78 GPR35 (0.78) GPR35MAPK1L3MBTL1CRHBPCRHR2
SCHEMBL31415060 0.78 ERN1 (0.59) GPR35CRHBPCRHR2ALDH1A1TDP1
SCHEMBL408308 0.78 ERN1 (0.59) GPR35CRHBPCRHR2ALDH1A1TDP1
SCHEMBL3463151 0.77 GPR35 (0.50) GPR35CRHBPCRHR2ALDH1A1TDP1
SCHEMBL4337102 0.74 CXCR1 (0.51) GPR35MAPK1L3MBTL1CRHBPCRHR2
SCHEMBL3785880 0.73 MAP4K4 (0.50) HSD17B10ALDH1A1TDP1CYP3A4CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130078213-A1 THROMBOPOIETIN MIMETICS GLAXOSMITHKLINE LLC 2013-03-28 US disclosed
EP-1889838-B1 Thrombopoietin mimetics SMITHKLINE BEECHAM CORP (US) 2009-10-14 EP disclosed
EP-1889838-A1 Thrombopoietin mimetics SmithKline Beecham Corporation (US) 2008-02-20 EP disclosed
EP-1864981-A1 Thrombopoietin mimetics SmithKline Beecham Corporation (US) 2007-12-12 EP disclosed
US-20070129338-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129338-A1 THROMBOPOIETIN MIMETICS MPL, THPO, TEK GPR35 2399/4885ALOX15 394/4885MAPK1 1691/4885
US-20130078213-A1 THROMBOPOIETIN MIMETICS MPL, THPO, TEK GPR35 2399/4885ALOX15 394/4885MAPK1 1691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.